Invited review: Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications (Q40849984)

24 September 2017

1 reference

title

Invited review: Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications (English)

1 reference

24 September 2017

0 references

Giacobini E

1

1 reference

24 September 2017

1 May 1998

1 reference

Neurochemistry International

24 September 2017

1 reference

24 September 2017

32

1 reference

24 September 2017

5-6

1 reference

24 September 2017

413-419

1 reference

Ketamine-induced postanesthetic delirium attenuated by tetrahydroaminoacridine

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900124-1

7 January 2021

Double-blind, placebo-controlled study of metrifonate, an acetylcholinesterase inhibitor, for Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900124-1

7 January 2021

A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900124-1

7 January 2021

The cholinergic system in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900124-1

7 January 2021

Potentiation of the neuromuscular effect of succinylcholine by tetrahydro-amino-acridine

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900124-1

7 January 2021

Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900124-1

7 January 2021

The effects of physostigmine on acetylcholinesterase activity of CSF plasma and brain. A comparison of intravenous and intraventricular administration in beagle dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900124-1

7 January 2021

Direct comparison of cognitive facilitation by physostigmine and tetrahydroaminoacridine in two primate models.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900124-1

7 January 2021

Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900124-1

7 January 2021

The pharmacology of some new anti-cholinesterases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900124-1

7 January 2021

Long-term tacrine treatment in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900124-1

7 January 2021

Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900124-1

7 January 2021

Oral physostigmine and lecithin improve memory in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900124-1

7 January 2021

Long-term use of tacrine.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2897%2900124-1

7 January 2021

10.1016/S0197-0186(97)00124-1

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

9676739